be 2254 has been researched along with dexniguldipine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gross, G; Hanft, G; Mehdorn, HM | 1 |
Esbenshade, TA; Hirasawa, A; Minneman, KP; Murphy, TJ; Tanaka, T; Tsujimoto, G; Yano, J | 1 |
Han, C; Xu, K; Zhang, Y | 1 |
3 other study(ies) available for be 2254 and dexniguldipine
Article | Year |
---|---|
Demonstration of alpha 1A- and alpha 1B-adrenoceptor binding sites in human brain tissue.
Topics: Adrenergic alpha-Antagonists; Brain Chemistry; Calcium Channel Blockers; Cerebral Cortex; Dihydropyridines; Humans; In Vitro Techniques; Phenethylamines; Piperazines; Prazosin; Receptors, Adrenergic, alpha; Tetralones | 1989 |
Cloning of the human alpha 1d-adrenergic receptor and inducible expression of three human subtypes in SK-N-MC cells.
Topics: Adrenergic alpha-Antagonists; Animals; Base Sequence; Cell Line; Cloning, Molecular; Dihydropyridines; DNA Primers; DNA, Complementary; Gene Expression; Humans; Isopropyl Thiogalactoside; Molecular Sequence Data; Phenethylamines; Piperazines; Polymerase Chain Reaction; Rats; Receptors, Adrenergic, alpha-1; Recombinant Proteins; Restriction Mapping; Tetralones; Transfection | 1995 |
Alterations of cardiac alpha 1-adrenoceptor subtypes in hypothyroid rats.
Topics: Adrenergic alpha-Antagonists; Animals; Atrial Function; Binding, Competitive; Dihydropyridines; Dioxanes; DNA Primers; Heart Atria; Hypothyroidism; Male; Myocardial Contraction; Norepinephrine; Phenethylamines; Piperazines; Polymerase Chain Reaction; Protein Binding; Radioligand Assay; Rats; Receptors, Adrenergic, alpha; RNA, Messenger; Tetralones; Thiouracil | 1997 |